New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
RadNet, Inc.
RDNT
Shape
US Flag

NASDAQ

5B

Medical - Diagnostics & Research

Next Earning date - 06 Mar 2025

5B

Medical - Diagnostics & Research

Next Earning date - 06 Mar 2025

65.22USD
Shape-1.36 ( -2.05%)
favorite-chart

Relative Strenght

88
favorite-chart

Volume Buzz

-13%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

30%

Quote Panel

Shape
Updated January 14, 2025
1W -9.48 % 1M -16.13 % 3M -7.57 % 1Y 78.49 %

Key Metrics

Shape
  • Market Cap

    4.83B


  • Shares Outstanding

    74.03M


  • Share in Float

    65.07M


  • Dividende

    0


  • Earning Date

    06 Mar 2025


  • Price Target

    65.225


  • Average Volume

    520116


  • Beta

    1.751


  • Range

    35.16-93.65


  • Industry

    Medical - Diagnostics & Research


  • Website

    https://www.radnet.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

RDNT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$2B

Shape326%

2025-Revenue

$0.80

Shape184%

2025-EPS

$380M

Shape-11%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

97.00(48.72%)

Number of analyst

2

Last analyst upgrade/downgrade

Barclays

upgrade

Previous: Equal-Weight

2024-09-06

Now: Overweight

Loop Capital Markets

initialise

Previous: Not converted

2023-03-31

Now: Buy

CJS Securities

initialise

Previous: Not converted

2023-03-31

Now: Outperform

B. Riley Securities

initialise

Previous: Not converted

2023-03-31

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

-15%

0.11
vs 0.13

Q1.23

arrow
arrow

N/A

-0.08
vs -0.15

Q2.23

arrow
arrow

+60%

0.24
vs 0.15

Q3.23

arrow
arrow

+56%

0.14
vs 0.09

Q4.23

arrow
arrow

+82%

0.2
vs 0.11

Q1.24

arrow
arrow

+188%

0.07
vs -0.08

Q2.24

arrow
arrow

-33%

0.16
vs 0.24

Q3.24

arrow
arrow

+29%

0.18
vs 0.14

Q4.24

arrow
arrow

+14%

0.23
vs 0.2

Q1.25

arrow
arrow

-83%

0.01
vs 0.07

Sales GrowthShape

status-upYoY

Current

Estimates

Q4.22

arrow
arrow

+15%

383.9M  vs 333.1M

Q1.23

arrow
arrow

+14%

390.6M  vs 341.8M

Q2.23

arrow
arrow

+14%

403.7M  vs 354.4M

Q3.23

arrow
arrow

+15%

402M  vs 350M

Q4.23

arrow
arrow

+10%

420.4M  vs 383.9M

Q1.24

arrow
arrow

+11%

431.7M  vs 390.6M

Q2.24

arrow
arrow

+14%

459.7M  vs 403.7M

Q3.24

arrow
arrow

+15%

461.1M  vs 402M

Q4.24

arrow
arrow

+11%

466.2M  vs 420.4M

Q1.25

arrow
arrow

+8%

465M  vs 431.7M

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+1%

0.01
vs 0.02

Q1.23

arrow
arrow

-4%

-0.04
vs 0.01

Q2.23

arrow
arrow

+1%

0.01
vs -0.04

Q3.23

arrow
arrow

+3%

0.03
vs 0.01

Q4.23

arrow
arrow

0%

-0.00
vs 0.03

Q1.24

arrow
arrow

0%

-0.00
vs -0.00

Q2.24

arrow
arrow

0%

-0.00
vs -0.00

Q3.24

arrow
arrow

+2%

0.02
vs -0.00

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

148

148
vs 152

-3%

Q1.23

arrow
arrow

155

155
vs 148

5%

Q2.23

arrow
arrow

193

193
vs 155

25%

Q3.23

arrow
arrow

198

198
vs 193

3%

Q4.23

arrow
arrow

224

224
vs 198

13%

Q1.24

arrow
arrow

281

281
vs 224

25%

Q2.24

arrow
arrow

286

286
vs 281

2%

Q3.24

arrow
arrow

308

308
vs 286

8%

Earnings Growth

Latest News